These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

122 related articles for article (PubMed ID: 23385514)

  • 21. Minichromosome maintenance protein expression in benign nevi, dysplastic nevi, melanoma, and cutaneous melanoma metastases.
    Boyd AS; Shakhtour B; Shyr Y
    J Am Acad Dermatol; 2008 May; 58(5):750-4. PubMed ID: 18249467
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Morphometric, DNA, and proliferating cell nuclear antigen measurements in benign melanocytic lesions and cutaneous malignant melanoma.
    Björnhagen V; Bonfoco E; Brahme EM; Lindholm J; Auer G
    Am J Dermatopathol; 1994 Dec; 16(6):615-23. PubMed ID: 7864299
    [TBL] [Abstract][Full Text] [Related]  

  • 23. MSG-1 expression in benign and malignant melanocytic lesions of cutaneous and mucosal epithelium.
    Sedghizadeh PP; Williams JD; Allen CM; Prasad ML
    Med Sci Monit; 2005 Jul; 11(7):BR189-94. PubMed ID: 15990678
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Immunohistochemistry of p16 in nevi of pregnancy and nevoid melanomas.
    Koh SS; Roehmholdt BF; Cassarino DS
    J Cutan Pathol; 2018 Dec; 45(12):891-896. PubMed ID: 30178478
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Relative frequency of solitary melanocytic lesions of the oral mucosa.
    Buchner A; Merrell PW; Carpenter WM
    J Oral Pathol Med; 2004 Oct; 33(9):550-7. PubMed ID: 15357676
    [TBL] [Abstract][Full Text] [Related]  

  • 26. PRAME Expression in Melanocytic Tumors.
    Lezcano C; Jungbluth AA; Nehal KS; Hollmann TJ; Busam KJ
    Am J Surg Pathol; 2018 Nov; 42(11):1456-1465. PubMed ID: 30045064
    [TBL] [Abstract][Full Text] [Related]  

  • 27. p53 Protein expression in nevi and melanomas.
    Cristofolini M; Boi S; Girlando S; Zumiani G; Cristofolini P; Dalla Palma P; Doglioni C; Barbareschi M
    Arch Dermatol; 1993 Jun; 129(6):739-43. PubMed ID: 8507076
    [TBL] [Abstract][Full Text] [Related]  

  • 28. S100A6 protein expression is different in Spitz nevi and melanomas.
    Ribé A; McNutt NS
    Mod Pathol; 2003 May; 16(5):505-11. PubMed ID: 12748257
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Immunohistochemical expression of the glucose transporters Glut-1 and Glut-3 in human malignant melanomas and benign melanocytic lesions.
    Parente P; Coli A; Massi G; Mangoni A; Fabrizi MM; Bigotti G
    J Exp Clin Cancer Res; 2008 Sep; 27(1):34. PubMed ID: 18764953
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Expression of activated Akt in benign nevi, Spitz nevi and melanomas.
    Kantrow SM; Boyd AS; Ellis DL; Nanney LB; Richmond A; Shyr Y; Robbins JB
    J Cutan Pathol; 2007 Aug; 34(8):593-6. PubMed ID: 17640227
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Microphthalmia transcription factor expression in cutaneous benign, malignant melanocytic, and nonmelanocytic tumors.
    King R; Googe PB; Weilbaecher KN; Mihm MC; Fisher DE
    Am J Surg Pathol; 2001 Jan; 25(1):51-7. PubMed ID: 11145251
    [TBL] [Abstract][Full Text] [Related]  

  • 32. BAP1 and BRAFV600E expression in benign and malignant melanocytic proliferations.
    Piris A; Mihm MC; Hoang MP
    Hum Pathol; 2015 Feb; 46(2):239-45. PubMed ID: 25479927
    [TBL] [Abstract][Full Text] [Related]  

  • 33. JARID1B expression in human melanoma and benign melanocytic skin lesions.
    Kuźbicki L; Lange D; Strączyńska-Niemiec A; Chwirot BW
    Melanoma Res; 2013 Feb; 23(1):8-12. PubMed ID: 23262439
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Immunohistochemical localization of S-100 protein and its subunits in melanotic lesions in the oral mucosa and skin.
    Fujita S; Takahashi H; Tsuda N; Okabe H
    J Oral Pathol Med; 1991 Oct; 20(9):429-32. PubMed ID: 1804988
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Cyclin D1 overexpression in Spitz nevi: an immunohistochemical study.
    Nagasaka T; Lai R; Medeiros LJ; Brynes RK; McCourty A; Harada T; Saddik M
    Am J Dermatopathol; 1999 Apr; 21(2):115-20. PubMed ID: 10218669
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Proto-oncogene c-kit expression in malignant melanoma: protein loss with tumor progression.
    Montone KT; van Belle P; Elenitsas R; Elder DE
    Mod Pathol; 1997 Sep; 10(9):939-44. PubMed ID: 9310959
    [TBL] [Abstract][Full Text] [Related]  

  • 37. High expression of cytoplasmic phosphorylated CSE1L in malignant melanoma but not in benign nevi: phosphorylated CSE1L for the discrimination between melanoma and benign nevi.
    Chin SY; Wu PR; Shih YH; Yeh CM; Lee WR; Shen SC; Yeh KT; Jiang MC; Tseng JT
    Int J Clin Exp Pathol; 2015; 8(2):1393-401. PubMed ID: 25973023
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Phosphoinositide 3-kinase is not overexpressed in melanocytic lesions.
    Singh RS; Diwan AH; Zhang PS; Prieto VG
    J Cutan Pathol; 2007 Mar; 34(3):220-5. PubMed ID: 17302605
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Expression and prognostic significance of galectin-1 and galectin-3 in benign nevi and melanomas].
    Li ZW; Wang Y; Xue WC; Si L; Cui CL; Cao DF; Zhou LX; Guo J; Lu AP
    Zhonghua Bing Li Xue Za Zhi; 2013 Dec; 42(12):801-5. PubMed ID: 24507096
    [TBL] [Abstract][Full Text] [Related]  

  • 40. p16 expression: a marker of differentiation between childhood malignant melanomas and Spitz nevi.
    Al Dhaybi R; Agoumi M; Gagné I; McCuaig C; Powell J; Kokta V
    J Am Acad Dermatol; 2011 Aug; 65(2):357-363. PubMed ID: 21550132
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.